Table 2.
Changes in cardiac function under dobutamine stress assessed by MRI
| Variable | Change under dobutamine stress (%) | |
|---|---|---|
| Control (n = 6) | m-V59M (n = 5) | |
| Heart rate | 8 ± 2* | 6 ± 4* |
| Ejection fraction | 12 ± 3*** | 15 ± 2*** |
| End diastolic volume | −28 ± 6** | −20 ± 5** |
| End systolic volume | −48 ± 9*** | −52 ± 7*** |
| Stroke volume | −14 ± 6 | −1 ± 6 |
| Cardiac output | 8 ± 2* | 5 ± 2* |
Data are means ± SEM for 12-week-old control (n = 6) and m-V59M (n = 5) mice
Data were compared with those acquired before stress using a repeated-measures ANOVA (with genotype as a between-subject factor and dobutamine treatment as a within-subject factor)
* p < 0.05, ** p < 0.01 and *** p < 0.001 against pre-dobutamine data; there were no significant differences between control and m-V59M mice